CENTRUM HTA PROVIDES CONSULTANCY SERVICES CONCERNING PHARMACEUTICAL MARKET IN POLAND
THE COMPANY’S ACTIVITY COVERS A WIDE RANGE OF CONSULTANCY SERVICES CONCERNING, IN PARTICULAR: PRODUCTION OF HEALTH TECHNOLOGY ANALYSES FOR PHARMACEUTICALS AND MEDICAL PRODUCTS.
FULL HTA DOSSIER
- Decision Problem Analysis
- Clinical analysis
- Economic analysis
- Budget Impact Analysis
- Rationalization Analysis
CHARACTERISTICS OF THE PHARMACEUTICAL MARKET IN POLAND
REVIEW OF EPIDEMIOLOGICAL AND COST SPECIFIC DATA IN POLISH SETTINGS
SYSTEMATIC REVIEW OF CLINICAL TRIALS
BUDGET IMPACT ANALYSIS FOR GENERIC DRUGS
FULL TEXT PUBLICATIONS
WORKSHOPS
ON EBM AND HTA
ADVISORY BOARD
SCIENTIFIC CONFERENCES MATERIALS
FULL RANGE REIMBURSEMENT CONSULTING
HTA ANALYZES ARE DEVELOPED BY CENTRUM HTA WITH GREAT ACCURACY, FULLY ACCORDING TO THE CURRENT FORMAL REQUIREMENTS IN POLAND.
- Act of May 12, 2011 on reimbursement of medicines, foodstuffs for particular nutritional purposes and medical devices (as amended)
- Minimum requirements to be satisfied by the analysis contained in reimbursement application. The English version of Regulation of the Minister Of Health of 8 January 2021 on the minimum requirements to be satisfied by the analyses accounted for in the applications for reimbursement and setting the official sales price and for increasing the official sales price of a drug, a special purpose dietary supplement, a medical device, which do not have a reimbursed counterpart in a given indication
- Health Technology Assessment Guidelines Version 3.0 Warsaw, August 2016 (publication date 14 of September 2016)